Fatigue associated with multiple sclerosis: diagnosis, impact and management
- 1 June 2003
- journal article
- review article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 9 (3), 219-227
- https://doi.org/10.1191/1352458503ms904oa
Abstract
In patients with multiple sclerosis (MS) fatigue is the most common symptom and one of the most disabling features. A s many as 40% have described it as the single most disabling symptom - a higher percentage than weakness, spasticity, motor problems, or bowel or bladder problems. The etiology and patho physiology of MS-related fatigue remain unknown. Studies have failed to demonstrate an association between MS-related fatigue and the level of disability, clinical disease subtype, or gender, although recent data show an association between MS-related fatigue and depression and quality of life. Imaging studies using positron emission tomography suggest that fatigue in MS is related to hypometabolism of specific brain areas, including the frontal and subcortical circuits. The impact of fatigue on patient functioning and quality of life clearly warrants intervention. In addition to nonpharmacologic measures, such as exercise and energy conservation strategies, several pharmacologic agents have been evaluated for their ability to reduce MS-related fatigue, including amantadine, central nervous system stimulants (pemoline), and the novel wake-promoting agent modafinil.Keywords
This publication has 41 references indexed in Scilit:
- Fatigue in multiple sclerosis and its relationship to depression and neurologic disabilityMultiple Sclerosis Journal, 2000
- Mechanisms and management of fatigue in progressive neurological disordersCurrent Opinion in Neurology, 1996
- Psychosocial and neurological predictors of mental health in multiple sclerosis patientsJournal of Clinical Epidemiology, 1996
- Impact of aerobic training on fitness and quality of life in multiple sclerosisAnnals of Neurology, 1996
- Psychosocial correlates of fatigue in multiple sclerosisArchives of Physical Medicine and Rehabilitation, 1996
- Effects of exercise on muscle activation and metabolism in multiple sclerosisMuscle & Nerve, 1994
- A double‐blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosisNeurology, 1992
- Fatigue in Multiple SclerosisArchives of Neurology, 1988
- A Randomized Controlled Trial of Amantadine in Fatigue Associated With Multiple SclerosisCanadian Journal of Neurological Sciences, 1987
- Amantadine Therapy for Fatigue in Multiple SclerosisCanadian Journal of Neurological Sciences, 1985